Treatment FAQ

romosozumab-aqqg is used in the treatment of which medical condition

by Betsy Leuschke Published 2 years ago Updated 2 years ago
image

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture.Apr 9, 2019

What is Romosozumab-aqqg used for?

Romosozumab-aqqg injection is used to treat osteoporosis (condition in which the bones become thin and weak and break easily) in postmenopausal women (women who have experienced a change of life; end of menstrual periods) who have a high risk of a fracture or when other osteoporosis treatments did not help or could not be tolerated.

What is the normal range for Romosozumab aqqg?

Uses Romosozumab-aqqg is used to treat bone loss ( osteoporosis) for women after menopause who are at high risk of having broken bones ( fractures ). It …

Where do you inject Romosozumab aqqg?

Mar 09, 2022 · Romosozumab is a prescription medicine used to treat the symptoms of osteoporosis in postmenopausal women at high risk for fracture. Romosozumab is available under the following different brand names: Evenity, romosozumab-aqqg What Are Dosages of Romosozumab? Adult dosage Injectable solution 105mg/1.17mL (single-use prefilled syringe)

What should I know about Romosozumab before taking it?

Mar 11, 2022 · Romosozumab-aqqg is a humanized monoclonal antibody (IgG2) produced in a mammalian cell line (Chinese Hamster Ovary) by recombinant DNA technology that binds to and inhibits sclerostin. Romosozumab-aqqg has an approximate molecular weight of 149 kDa.

image

What is romosozumab-AQQG used for?

Romosozumab-aqqg injection is used to treat osteoporosis (thinning and weakening of the bones) in postmenopausal women who are at high risk of fracture (history of osteoporotic fracture) or have used another osteoporosis medicine that did not work well.Feb 1, 2022

What is romosozumab injection?

Romosozumab-aqqg injection is used to treat osteoporosis (condition in which the bones become thin and weak and break easily) in postmenopausal women (women who have experienced a change of life; end of menstrual periods) who have a high risk of a fracture or when other osteoporosis treatments did not help or could not ...May 15, 2019

What is Evenity used for?

Indication: EVENITY® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk of fracture, or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well.

What is Evenity for osteoporosis?

Evenity (romosozumab) is a sclerostin inhibitor. Sclerostin suppresses bone formation. Evenity is a prescription medicine used to treat osteoporosis in postmenopausal women with a high risk of bone fracture who cannot use other osteoporosis medications (or when other medications did not work).Jan 24, 2022

How is romosozumab given?

How is romosozumab given? The medication is injected once a month using two separate prefilled syringes for a full dose. Romosozumab should only be taken for one year, because its bone-making activity wanes after 12 months.Jul 17, 2019

What type of drug is romosozumab?

Evenity is a prescription medicine used to treat the symptoms of Osteoporosis. Evenity may be used alone or with other medications. Evenity belongs to a class of drugs called Monoclonal Antibodies, Endocrine.

How is Evenity given?

Each EVENITY® dose consists of 2 shots given under your skin every month by your doctor or healthcare provider. You should take calcium and vitamin D as your doctor tells you to while you receive EVENITY®.

Is Evenity an immunosuppressant?

EVENITY® is a humanized monoclonal antibody. As with all therapeutic proteins, there is potential for immunogenicity. Please see EVENITY® full Prescribing Information, including Medication Guide.

What is the difference between Prolia and Evenity?

Evenity quickly increased bone mineral density and decreases fracture risk, while Prolia increases bone mass while the patient is taking it. Evenity works by inhibiting a protein called sclerostin.Apr 10, 2019

Which is safer Evenity or Prolia?

This review also found that Evenity may be more effective than Prolia for preventing hip fractures or other non-spinal fractures. Also, the active drugs* in both Evenity and Prolia are recommended in current treatment guidelines for osteoporosis in females who've gone through menopause.Nov 6, 2020

What is the difference between Forteo and Evenity?

Evenity and Forteo belong to different drug classes. Evenity is a sclerostin inhibitor and Forteo is a man-made form of parathyroid hormone. Side effects of Evenity and Forteo that are similar include joint pain, headache, muscle cramps or spasms, and neck pain.

Which is better Tymlos or Evenity?

By contrast, another high-powered IV medication, romosozumab (Evenity) only reduced fracture risk 71%. That means Tylmos is about a 21% better at reducing spinal fractures than even Evenity (15% absolute difference).Oct 23, 2019

What is romosozumab used for?

Romosozumab-aqqg is used to treat bone loss ( osteoporosis) for women after menopause who are at high risk of having broken bones ( fractures ). It works by increasing bone density and strength. This effect helps to decrease the risk of having a fracture.

What are the symptoms of a heart attack?

Get medical help right away if you have symptoms of a heart attack (such as chest/jaw/left arm pain, shortness of breath, unusual sweating) or signs of a stroke (such as weakness on one side of the body, trouble speaking, sudden vision changes, confusion).

Can drug interactions change your medication?

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist.

Is First Databank copyrighted?

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

Does romosozumab cause a stroke?

This medication may rarely increase the risk for a heart attack, stroke, or sudden death. Before starting treatment with romosozumab-aqqg, tell your doctor if you had a heart attack or stroke within the past year. Get medical help right away if you have symptoms of a heart attack (such as chest/jaw/left arm pain, shortness of breath, unusual sweating) or signs of a stroke (such as weakness on one side of the body, trouble speaking, sudden vision changes, confusion).

What is a romosozumab?

Romosozumab-aqqg is a humanized monoclonal antibody (IgG2) produced in a mammalian cell line (Chinese Hamster Ovary) by recombinant DNA technology that binds to and inhibits sclerostin. Romosozumab-aqqg has an approximate molecular weight of 149 kDa.

How many syringes are needed for 210 mg of EVENITY?

Two separate syringes (and two separate subcutaneous injections) are needed to administer the total dose of 210 mg of EVENITY. Inject two 105 mg/1.17 mL prefilled syringes, one after the other.

Does EVENITY increase bone mass?

EVENITY inhibits the action of sclerostin, a regulatory factor in bone metabolism. EVENITY increases bone formation and, to a lesser extent, decreases bone resorption. Animal studies showed that romosozumab-aqqg stimulates new bone formation on trabecular and cortical bone surfaces by stimulating osteoblastic activity resulting in increases in trabecular and cortical bone mass and improvements in bone structure and strength [see Nonclinical Toxicology and Clinical Studies ].

Is romosozumab Aqqg based on age?

No clinically significant differences in the pharmacokinetics of romosozumab-aqqg were observed based on age (20-89 years), sex, race, disease state (low bone mass or osteoporosis), prior exposure to alendronate, or renal impairment including end-stage renal disease ( ESRD) requiring dialysis. The effect of ESRD not requiring dialysis on the pharmacokinetics of romosozumab-aqqg is unknown.

What is the purpose of the term "evenity"?

EVENITY is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture , defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.

Does EVENITY increase myocardial infarction?

EVENITY may increase the risk of myocardial infarction, stroke, and cardiovascular death [see WARNINGS AND PRECAUTIONS ]. EVENITY should not be initiated in patients who have had a myocardial infarction or stroke within the preceding year.

What are the reactions that occur with EVENITY?

Hypersensitivity reactions, including angioedema, erythema multiforme, dermatitis, rash, and urticaria have occurred in EVENITY-treated patients. If an anaphylactic or other clinically significant allergic reaction occurs, initiate appropriate therapy and discontinue further use of EVENITY [see CONTRAINDICATIONS and ADVERSE REACTIONS ].

How long does romosozumab last?

Limit the duration of treatment to 12 doses. The anabolic effect of romosozumab decreases after 12 monthly doses. Consider therapy with an anti-resorptive agent if osteoporosis treatment remains warranted. Supplement with adequate calcium and vitamin D during treatment with romosozumab.

What is the purpose of IgG2?

Parenteral humanized IgG2 monoclonal antibody and sclerostin inhibitor#N#Used for the treatment of osteoporosis in postmenopausal women at high risk for fracture or patients who have failed or are intolerant to other therapy#N#Associated with a higher incidence of major adverse cardiac events

Where to inject a syringe?

Recommended injection sites include the thigh, abdomen, or outer area of the upper arm. Rotate injection sites with each dose. If using the same injection site, ensure that it is not the same spot on the injection site used for a previous injection.

What is MACE in medical terms?

A higher incidence of major adverse cardiac events (MACE), a composite endpoint of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, occurred in patients treated with romosozumab compared to those treated with alendronate during clinical trials. [64057]

Can romosozumab cause osteonecrosis?

Osteonecrosis of the jaw (ONJ) has been reported in patients receiving romosozumab. It is generally associated with tooth extraction and/or local infection with delayed healing; however, it may occur spontaneously. Perform a routine oral exam before starting romosozumab. Risk factors for ONJ include anemia, cancer, radiation therapy, coagulopathy, preexisting dental disease or infection, and poor oral hygiene. Concomitant use of other drugs associated with ONJ, including chemotherapy, bisphosphonates, denosumab, angiogenesis inhibitors, and corticosteroid therapy, may increase the risk of developing ONJ. For patients requiring invasive dental work, use clinical judgment to guide the management of each patient based on benefit-risk assessment. Refer patients who develop or are suspected of having ONJ to a dentist or oral surgeon for care. Dental surgery to treat ONJ may exacerbate the condition. Consider romosozumab discontinuation based on benefit-risk assessment. [64057] For antiresorptive therapy, which may follow romosozumab treatment, preventive measures and continued regular follow-up with a dentist are recommended to minimize the risk of osteonecrosis. [64058]

Is romosozumab safe for breast feeding?

Romosozumab is not indicated for use in women of reproductive potential, including during breast-feeding. In pregnant rats given romosozumab at weekly doses equivalent to 1.5, 19, or 56 times the clinical exposure after a monthly subcutaneous dose of 210 mg based on AUC comparison from 6 weeks before cohabitation through mating and lactation, romosozumab was dose-dependently present in offspring serum on postnatal day 21 at 0.01 to 2.4 times maternal exposure due to maternal and/or lactational exposure. [64057]

Does romosozumab increase bone mass?

Animal studies demonstrated that romosozumab increases trabecular and cortical bone mass and improves bone structure and strength through stimulation of new bone formation on trabecular and cortical bone surfaces by increasing osteoblastic activity. [64057]

What is evenity aqqg?

Evenity contains the active drug romosozumab-aqqg, which is a type of drug called a monoclonal antibody. (For more information, see the “ How Evenity works ” section below.) Evenity comes as a solution inside a single-use, prefilled syringe.

What is the difference between biologics and drugs?

A biologic drug is made from living cells, while other drugs are made from chemicals. Drugs made from chemicals can have generics, which are exact copies of the active drug in the brand-name medication. Biologics, on the other hand, can’t be copied exactly. So, instead of a generic, biologics have biosimilars.

How many mg of evenity is in a syringe?

Evenity comes as a solution inside a single-use, prefilled syringe. Each syringe contains 105 milligrams (mg) of active drug in 1.7 milliliters of solution. Evenity’s active drug is called romosozumab-aqqg.

What are the symptoms of an allergic reaction?

flushing (warmth, swelling, and redness in your skin) A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include: swelling under your skin, typically in your eyelids, lips, hands, or feet. swelling of your tongue, mouth, or throat. trouble breathing.

Can evenity cause side effects?

Evenity can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Evenity. These lists do not include all possible side effects. For more information about the possible side effects of Evenity, talk with your doctor or pharmacist.

Does Evenity cause heart problems?

Evenity can increase your risk for heart attack and stroke. It can also increase your risk for death due to a cardiovascular (heart or blood vessel) problem. In fact, Evenity has a boxed warning#N#Trusted Source#N#for these side effects. A boxed warning is the most serious warning from the Food and Drug Administration (FDA).

What does FDA mean when it says "evenity"?

The Food and Drug Administration (FDA) approves prescription drugs such as Evenity to treat certain conditions. Evenity may also be used off-label for other conditions. Off-label use is when a drug that’s approved to treat one condition is used to treat a different condition.

What is romosozumab used for?

What is romosozumab? Romosozumab is used to treat osteoporosis in postmenopausal women with a high risk of bone fracture who cannot use other osteoporosis medications (or when other medications did not work). Romosozumab may also be used for purposes not listed in this medication guide.

How often is romosozumab given?

Romosozumab is usually given as 2 injections once per month for 1 year. Romosozumab is only part of a complete treatment program that may include taking daily calcium and vitamin D supplements. Take only the amount your doctor has prescribed. Pay special attention to your dental hygiene.

What are the side effects of romosozumab?

Common side effects may include: headache; or. joint pain. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Romosozumab side effects (more detail)

What are the symptoms of a symtom?

Seek emergency medical help if you have symptoms such as: chest pain or pressure, shortness of breath, feeling light-headed, sudden numbness or weakness, problems with vision or speech, or loss of balance.

Can you take vitamin D every day?

if you cannot take calcium and vitamin D supplements every day. This medicine may cause jaw bone problems ( osteonecrosis ). The risk is highest in people with cancer, blood cell disorders, pre-existing dental problems, or people treated with steroids, chemotherapy, or radiation. Ask your doctor about your own risk.

What are the symptoms of a heart attack?

Seek emergency medical help if you have symptoms of a heart attack or stroke: chest pain or pressure, shortness of breath, feeling light-headed, sudden numbness or weakness, problems with vision or speech, or loss of balance. Call your doctor at once if you have:

Can you shake a prefilled syringe?

Do not shake the prefilled syringe or you may ruin the medicine. Do not use the medicine if it looks cloudy or has particles in it. Call your pharmacist for a new prescription. Each prefilled syringe is for one use only. Throw it away after one use, even if there is still medicine left inside.

What is the BMD score for osteoporosis?

Current guidelines define osteoporosis as a bone mineral density (BMD) T-score of -2.5 or below, and osteopenia as a T-score between -1 and -2.5. Additionally, guidelines state that osteoporosis can also be diagnosed by the history of a low-trauma spine or hip fracture regardless of BMD, a history of a fragility fracture in osteopenic patients, or in osteopenic patients with an elevated fracture risk as defined by the FRAX® fracture assessment tool. 1 Available literature defines high risk for fracture as bone mineral density (BMD) T-scores of -3.5 or less, while it defines severe osteoporosis as T-scores of -2.5 or less with at least one fragility fracture.2-6 The FRAX tool is designed to assist clinicians in predicting the ten-year probability of fracture with or without the addition of femoral neck bone mineral density (BMD).7

What is certificate of coverage?

Some Certificates of Coverage allow for coverage of experimental/investigational/unproven treatments for life-threatening illnesses when certain conditions are met. The member specific benefit plan document must be consulted to make coverage decisions for this service. Some states mandate benefit coverage for off-label use of medications for some diagnoses or under some circumstances when certain conditions are met. Where such mandates apply, they supersede language in the benefit document or in the medical or drug policy. Benefit coverage for an otherwise unproven service for the treatment of serious rare diseases may occur when certain conditions are met. See the Policy and Procedure addressing the treatment of serious rare diseases.

How long is evenity good for?

The clinical benefit of Evenity has not been demonstrated beyond 12 months in phase 3 clinical trials. The continued use of Evenity beyond 12 months is unproven and not medically necessary.10-13

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9